Nnexxahealth
HomeIssues AboutPartnersContact Sign in Get the magazine
The index

Topics and names

Every subject, person and organisation we have written about, across the magazine.
1 Cover feature

Nothing filed under it yet.

2 Citizens & care
Cancer Carcinogens Cardiovascular health Chemicals Climate Dengue Infectious diseases Medicines Mental health Non-communicable diseases (NCDs) Prevention Rare Rare diseases Shamonda virus Workforce Workplace Critical Medicines Act Medical Devices and In Vitro Diagnostics Regulation Safe Hearts Plan
3 Voices

Nothing filed under it yet.

3 Made in Europe
Approvals Devices Diagnostics Manufacturing Medicines Pharma Pricing Therapies The Presidency of the Council
3 Innovation
Academia in action AI Biotech Cell and gene therapies Clusters Cybersecurity Data Devices Diagnostics Manufacturing Medicines Partnerships Pharma Research Trials
2 Competitiveness
Industry Manufacturing Medicines Pharma Regulation Biotech Act I
5 Health systems
Approvals Care Cybersecurity Data Pharmacists Preparedness Prevention Shortages Workforce
— Money
Budgets Capital EU4health European Competitiveness Fund MFF
—Every topic
AI1 Approvals2 Biotech1 Cancer1 Capital2 Cardiovascular health3 Cell and gene therapies1 Clusters1 Devices1 Medicines3 Mental health1 Pharmacists1 Prevention4 Pricing1 Research1 Shortages1 Therapies1 Trials2 Workforce2
—People
Andràs Tivadar Kulja1 Bogi Eliasen1 Christina Egelund1 Christoph von der Goltz1 Jennifer Carroll MacNeill1 Jordi Ortiz1 Martin Beck1 Nikos Papandreou1 Prof. Serena Zacchigna1 Søren Møller1 Stine Bosse1 Tom Murray1 Tomer Feffer1
—Organisations
Bayer1 Boehringer Ingelheim1 Catalonia Trade & Investment1 European Parliament3 European Society of Radiology2 International Centre for Genetic Engineering and Biotechnology1 Movement Health Foundation1 Novo Holdings1 Prof. Rodrigo Salgado1 University of Trieste1